Nimodipine 30mg Tablets Roussel
What is Nimodipine 30 mg? Nimodipine 30 mg is a prescription oral tablet belonging to the calcium channel blocker family, but with a highly specialised and unique role — it is specifically designed to protect the brain. Unlike standard calcium channel blockers used to treat blood pressure (such as amlodipine or nifedipine), Nimodipine is engineered to cross the blood-brain barrier and act selectively on cerebral blood vessels. It is the internationally recognised standard of care for preventing serious neurological complications following a subarachnoid haemorrhage (SAH) — a life-threatening bleed into the space surrounding the brain.
What is Nimodipine 30 mg used for? The primary and licensed indication is the prevention and treatment of ischaemic neurological deficits following subarachnoid haemorrhage due to ruptured cerebral aneurysm. Treatment is initiated as soon as possible after the onset of bleeding — ideally within 4 days — and continued for a full 21-day course. Beyond this primary use, neurologists also prescribe Nimodipine off-label for vascular dementia, prevention of migraine with aura, and management of certain vestibular disorders, always under specialist direction.
Dosage and how to take it The standard adult dose for subarachnoid haemorrhage is 60 mg (two 30 mg tablets) taken every 4 hours — that is six times daily — for 21 consecutive days. Tablets should be swallowed whole with a small amount of water and taken consistently at the prescribed intervals, including overnight. Always follow the exact dose and timing prescribed by your specialist. Do not stop the course early without medical advice. If you miss a dose, take it as soon as you remember — but if it is almost time for the next dose, skip the missed one and continue your regular schedule.
Critical warning — oral use only Nimodipine tablets are for oral (swallowing) use only. Under no circumstances should the contents of the tablet be extracted and injected intravenously. There have been documented cases of fatal outcomes resulting from the accidental IV injection of Nimodipine. The tablet must always be swallowed whole.
Common side effects The most frequently reported side effects are a drop in blood pressure (hypotension), headache, facial flushing, nausea, stomach discomfort, dizziness, and bradycardia (slow heart rate). Blood pressure should be monitored closely throughout the 21-day course. If significant hypotension occurs, the dose may need to be reduced by your doctor — do not adjust the dose yourself.
Who should not take Nimodipine 30 mg? Nimodipine is contraindicated in patients with severe liver failure (as the drug is extensively metabolised by the liver), known hypersensitivity to dihydropyridine calcium channel blockers, and clinically significant low blood pressure. It should be used with caution in patients with cerebral oedema, severely raised intracranial pressure, heart failure, and impaired renal function. It is not recommended during pregnancy or breastfeeding unless the benefit clearly outweighs the risk, as assessed by a specialist.
Storage Store below 25°C, protected from light and moisture. Keep in the original packaging. Do not use after the expiry date printed on the pack. Keep out of reach of children.
Why buy from Amkamed Pharmaceuticals? We supply genuine, manufacturer-sealed Nimodipine tablets to hospitals, specialist clinics, and prescription-holding patients across Nigeria. A valid prescription from a neurologist, neurosurgeon, or specialist physician is required to complete your order.